- Home
- TVTX vs CMPR Comparison
TVTX vs CMPR Comparison
Compare TVTX & CMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- CMPR
- Stock Information
- Founded
- TVTX 2008
- CMPR 1994
- Country
- TVTX United States
- CMPR Ireland
- Employees
- TVTX N/A
- CMPR N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- CMPR Publishing
- Sector
- TVTX Health Care
- CMPR Consumer Discretionary
- Exchange
- TVTX Nasdaq
- CMPR Nasdaq
- Market Cap
- TVTX 1.4B
- CMPR 1.2B
- IPO Year
- TVTX N/A
- CMPR N/A
- Fundamental
- Price
- TVTX $15.63
- CMPR $53.19
- Analyst Decision
- TVTX Strong Buy
- CMPR Strong Buy
- Analyst Count
- TVTX 16
- CMPR 2
- Target Price
- TVTX $33.33
- CMPR $69.50
- AVG Volume (30 Days)
- TVTX 1.2M
- CMPR 268.5K
- Earning Date
- TVTX 08-06-2025
- CMPR 07-29-2025
- Dividend Yield
- TVTX N/A
- CMPR N/A
- EPS Growth
- TVTX N/A
- CMPR N/A
- EPS
- TVTX N/A
- CMPR 0.58
- Revenue
- TVTX $273,533,000.00
- CMPR $3,403,079,000.00
- Revenue This Year
- TVTX $71.61
- CMPR $4.65
- Revenue Next Year
- TVTX $43.45
- CMPR $3.16
- P/E Ratio
- TVTX N/A
- CMPR $91.71
- Revenue Growth
- TVTX 75.65
- CMPR 3.38
- 52 Week Low
- TVTX $7.93
- CMPR $35.21
- 52 Week High
- TVTX $25.29
- CMPR $104.92
- Technical
- Relative Strength Index (RSI)
- TVTX 49.00
- CMPR 64.01
- Support Level
- TVTX $15.28
- CMPR $47.76
- Resistance Level
- TVTX $15.97
- CMPR $58.14
- Average True Range (ATR)
- TVTX 0.62
- CMPR 2.46
- MACD
- TVTX -0.06
- CMPR 0.83
- Stochastic Oscillator
- TVTX 28.78
- CMPR 69.18
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About CMPR Cimpress plc (Ireland)
Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.